Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Griggs

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Archives of Biochemistry and Biophysics|August 2, 2008
Proprotein convertase activation of aggrecanases in cartilage in situAnne-Marie Malfait, Elizabeth C Arner, Ruo-Hua Song, et al.
Clinical & Experimental Metastasis|June 1, 2004
Anti-metastatic properties of RGD-peptidomimetic agents S137 and S247Kristen E Shannon, Jeffery L Keene, Steven L Settle, et al.
Journal of Medicinal Chemistry|May 6, 2016
Effects of N-Substitutions on the Tetrahydroquinoline (THQ) Core of Mixed-Efficacy μ-Opioid Receptor (MOR)/δ-Opioid Receptor (DOR) LigandsAubrie A Harland, Aaron M Bender, Nicholas W Griggs, et al.
Journal of Medicinal Chemistry|March 28, 2019
Dual Pharmacophores Explored via Structure-Activity Relationship (SAR) Matrix: Insights into Potent, Bifunctional Opioid Ligand DesignAnthony F Nastase, Jessica P Anand, Aaron M Bender, et al.
Cellular and Molecular Gastroenterology and Hepatology|February 9, 2017
Inhibitors of Arg-Gly-Asp-Binding Integrins Reduce Development of Pancreatic Fibrosis in MiceBarbara Ulmasov, Brent A Neuschwander-Tetri, Jinping Lai, et al.
ACS Chemical Neuroscience|June 15, 2019
Novel Dimethyltyrosine-Tetrahydroisoquinoline Peptidomimetics with Aromatic Tetrahydroisoquinoline Substitutions Show <i>in Vitro</i> Kappa and Mu Opioid Receptor AgonismDeanna Montgomery, Jessica P Anand, Nicholas W Griggs, et al.
ACS Chemical Neuroscience|April 21, 2018
Synthesis and Pharmacological Evaluation of Novel C-8 Substituted Tetrahydroquinolines as Balanced-Affinity Mu/Delta Opioid Ligands for the Treatment of PainAnthony F Nastase, Nicholas W Griggs, Jessica P Anand, et al.
Hepatology (Baltimore, Md.)|June 5, 2013
CD73 (ecto-5'-nucleotidase) hepatocyte levels differ across mouse strains and contribute to mallory-denk body formationNatasha T Snider, Nicholas W Griggs, Amika Singla, et al.
Journal of Medicinal Chemistry|August 3, 2021
Optimization of the Urea Linker of Triazolopyridazine MMV665917 Results in a New Anticryptosporidial Lead with Improved Potency and Predicted hERG Safety MarginEdmund Oboh, Tanner J Schubert, Jose E Teixeira, et al.
Journal of Medicinal Chemistry|June 2, 2023
Structure-Activity Relationship Studies of the Aryl Acetamide Triazolopyridazines against Tanner J Schubert, Edmund Oboh, Hannah Peek, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Archives of Biochemistry and Biophysics|August 2, 2008
Proprotein convertase activation of aggrecanases in cartilage in situAnne-Marie Malfait, Elizabeth C Arner, Ruo-Hua Song, et al.
Clinical & Experimental Metastasis|June 1, 2004
Anti-metastatic properties of RGD-peptidomimetic agents S137 and S247Kristen E Shannon, Jeffery L Keene, Steven L Settle, et al.
Journal of Medicinal Chemistry|May 6, 2016
Effects of N-Substitutions on the Tetrahydroquinoline (THQ) Core of Mixed-Efficacy μ-Opioid Receptor (MOR)/δ-Opioid Receptor (DOR) LigandsAubrie A Harland, Aaron M Bender, Nicholas W Griggs, et al.
Journal of Medicinal Chemistry|March 28, 2019
Dual Pharmacophores Explored via Structure-Activity Relationship (SAR) Matrix: Insights into Potent, Bifunctional Opioid Ligand DesignAnthony F Nastase, Jessica P Anand, Aaron M Bender, et al.
Cellular and Molecular Gastroenterology and Hepatology|February 9, 2017
Inhibitors of Arg-Gly-Asp-Binding Integrins Reduce Development of Pancreatic Fibrosis in MiceBarbara Ulmasov, Brent A Neuschwander-Tetri, Jinping Lai, et al.
ACS Chemical Neuroscience|June 15, 2019
Novel Dimethyltyrosine-Tetrahydroisoquinoline Peptidomimetics with Aromatic Tetrahydroisoquinoline Substitutions Show <i>in Vitro</i> Kappa and Mu Opioid Receptor AgonismDeanna Montgomery, Jessica P Anand, Nicholas W Griggs, et al.
ACS Chemical Neuroscience|April 21, 2018
Synthesis and Pharmacological Evaluation of Novel C-8 Substituted Tetrahydroquinolines as Balanced-Affinity Mu/Delta Opioid Ligands for the Treatment of PainAnthony F Nastase, Nicholas W Griggs, Jessica P Anand, et al.
Hepatology (Baltimore, Md.)|June 5, 2013
CD73 (ecto-5'-nucleotidase) hepatocyte levels differ across mouse strains and contribute to mallory-denk body formationNatasha T Snider, Nicholas W Griggs, Amika Singla, et al.
Journal of Medicinal Chemistry|August 3, 2021
Optimization of the Urea Linker of Triazolopyridazine MMV665917 Results in a New Anticryptosporidial Lead with Improved Potency and Predicted hERG Safety MarginEdmund Oboh, Tanner J Schubert, Jose E Teixeira, et al.
Journal of Medicinal Chemistry|June 2, 2023
Structure-Activity Relationship Studies of the Aryl Acetamide Triazolopyridazines against Tanner J Schubert, Edmund Oboh, Hannah Peek, et al.
Pageof 9